In this study, we set out to evaluate the role of CLU in this heat shock response in OS since CLU is dramatically induced by ZOL treatment and CLU inhibitor is currently in phase III clinical Trial in prostate cancer. This evidence concerns the gene CLU and prostate carcinoma.